Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marlin Global Limited Director's Dealing 2022

Nov 11, 2022

66231_rns_2022-11-11_9b838dde-4692-4120-9277-87fae94ed7c5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [44 x 13] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited;and
Name of listed issuer: Marlin Global Limited
Date this disclosure made: 11-Nov-22
Date of last disclosure: 28-Sep-22
Director or senior managergiving disclosure
Full name(s): RichardAndrewCoupe
Name of listedissuer: MarlinGlobal Limited
Name of related body corporate (ifapplicable): n/a
Position heldin listedissuer: Director
Summary of acquisition or disposal of relevant interest(excluding specified derivatives)Class ofaffected quotedfinancialproducts:Nature ofthe affectedrelevantinterest(s):
Class ofaffected quotedfinancialproducts:
Nature ofthe affectedrelevantinterest(s):
**For that relevant interest- **
Number heldinclass before acquisitionordisposal:
Number heldinclass afteracquisitionordisposal:
Currentregisteredholder(s):
Registeredholder(s) once transfers areregistered:
Summary of acquisition or disposal of specified derivatives relevant interest(if applicab le)
Type ofaffected derivative: Warrants
Class ofunderlyingfinancialproducts: Ordinary Shares
The notional value of the derivative (if any) or the notional amount of underlying financialproducts (ifany): $1,185.20 (23,704 warrants @ $0.05warrant price)
Astatement as towhetherthe derivativeis cashsettled orphysically settled: Cashsettled
Maturity date ofthe derivative (ifany): 10-Nov-23
Expiry date ofthe derivative(ifany): 10-Nov-23
The price specified in the terms of the derivative (if any): $0.99 less dividends declared over theperiod.
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: n/a
_For that derivative,- _Parties to the derivative:If the director or senior manager is not a party to the derivative, the nature of the relevantinterestinthe derivative:
Parties to the derivative: RichardAndrewCoupe
If the director or senior manager is not a party to the derivative, the nature of the relevantinterestinthe derivative: n/a
Details of transactionsgiving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates: One
3-Nov-22
Issue of 23,704 warrants pursuant to thewarrant terms announced on 18 October2022.
None
Nil (warrants issued for no cost to allshareholders on the record date of 2November 2022)
One
Whether relevantinterestswere acquired ordisposed ofduring a closed period: Not during closed period
Whether prior written clearance was provided to allow the acquisition or disposal toproceed during the closed period: n/a
Date ofthe prior writtenclearance (ifany): n/a
Summary of other relevant interests after acquisition or disposal:Class ofquotedfinancialproducts:Nature of relevant interest:For that relevant interest,-
Ordinary Shares
Registered holder and beneficial interest
94,816 ordinary shares
RichardAndrewCoupe
The notional value of the derivative (if any) or the notional amount of underlying financialproducts (ifany):
Astatement as towhetherthe derivativeis cashsettled orphysically settled:
Maturity date ofthe derivative (ifany):
Expiry date ofthe derivative (ifany):
The price's specified terms (ifany):
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts:
_For that derivative relevant interest,- _
_, _
Parti es to the derivative:
If theinter director or senior manager is not a party to the derivative, the nature of the relevantestinthe derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [75 x 19] intentionally omitted <==

11-Nov-22